(Q34530258)

2 August 2017

Clinical course after change of immunomodulating therapy in relapsing-remitting multiple sclerosis (English)

1 reference

relapsing-remitting multiple sclerosis

2 August 2017

0 references

0 references

author name string

C Caon

1

1 reference

2 August 2017

M Din

2

1 reference

2 August 2017

W Ching

3

1 reference

2 August 2017

A Tselis

4

1 reference

2 August 2017

R Lisak

5

1 reference

2 August 2017

O Khan

6

1 reference

2 August 2017

1 May 2006

1 reference

European Journal of Neurology

2 August 2017

1 reference

2 August 2017

13

1 reference

2 August 2017

5

1 reference

2 August 2017

471-474

1 reference

Comparative assessment of immunomodulating therapies for relapsing-remitting multiple sclerosis

2 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01273.X

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01273.X

Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01273.X

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01273.X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01273.X

10.1111/J.1468-1331.2006.01273.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference